Title:
Advanced Medical Technology Association - Comment

Abstract:
Jeffrey Secunda, VP, AdvaMed - ...provides this submission in response to the Food and Drug Administration’s (FDA’s) request for comments on its proposed rule titled “Supplemental Applications Proposing Labeling Changes for Approved Drugs, Biologics, and Medical Devices.”....